• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians.载脂蛋白相关磷脂酶 A2 与非裔美国人和白种人冠心病的相关性。
J Clin Endocrinol Metab. 2010 May;95(5):2376-83. doi: 10.1210/jc.2009-2498. Epub 2010 Mar 1.
2
Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.载脂蛋白 E4 和脂蛋白相关磷脂酶 A2 协同增加心血管风险。
Atherosclerosis. 2012 Jul;223(1):230-4. doi: 10.1016/j.atherosclerosis.2012.04.021. Epub 2012 May 8.
3
Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.在一个双种族人群中,Lp-PLA(2) 活性与等位基因特异性 Lp(a) 水平的关联。
Atherosclerosis. 2010 Aug;211(2):526-30. doi: 10.1016/j.atherosclerosis.2010.03.021. Epub 2010 Apr 20.
4
Racial variation in lipoprotein-associated phospholipase A₂ in older adults.老年人脂蛋白相关磷脂酶 A₂的种族差异。
BMC Cardiovasc Disord. 2011 Jun 29;11:38. doi: 10.1186/1471-2261-11-38.
5
Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress: a case-control study.脂蛋白相关磷脂酶A2活性与冠状动脉疾病及氧化应激标志物相关:一项病例对照研究。
Am J Clin Nutr. 2008 Sep;88(3):630-7. doi: 10.1093/ajcn/88.3.630.
6
Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literature.脂蛋白相关磷脂酶 A2 在人口统计学特征和心血管危险因素中的变化:文献系统评价。
Atherosclerosis. 2012 Nov;225(1):11-21. doi: 10.1016/j.atherosclerosis.2012.06.020. Epub 2012 Jun 21.
7
Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up.载脂蛋白 A(2)相关脂蛋白结合高密度脂蛋白与稳定型冠状动脉疾病患者心脏死亡风险降低相关:一项 3 年随访研究。
J Am Coll Cardiol. 2012 Nov 13;60(20):2053-60. doi: 10.1016/j.jacc.2012.06.057. Epub 2012 Oct 17.
8
Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians.血清淀粉样蛋白 A 和五聚素-3 与非裔美国人和白种人脂蛋白(a)等位基因特异性水平的差异关联。
Transl Res. 2011 Aug;158(2):92-8. doi: 10.1016/j.trsl.2011.01.004. Epub 2011 Feb 5.
9
High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.高水平的携带小载脂蛋白(a)异构体的脂蛋白(a)与非裔美国男性和白人男性的冠状动脉疾病有关。
Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2619-24. doi: 10.1161/01.atv.20.12.2619.
10
Elevated plasma lipoprotein-associated phospholipase A₂ activity is associated with plaque rupture in patients with coronary artery disease.血浆脂蛋白相关磷脂酶 A₂ 活性升高与冠心病患者斑块破裂有关。
Chin Med J (Engl). 2011 Aug;124(16):2469-73.

引用本文的文献

1
Serum levels of lipoprotein-associated phospholipase A2 are associated with coronary atherosclerotic plaque progression in diabetic and non-diabetic patients.脂蛋白相关磷脂酶 A2 的血清水平与糖尿病和非糖尿病患者的冠状动脉粥样硬化斑块进展有关。
BMC Cardiovasc Disord. 2024 May 14;24(1):251. doi: 10.1186/s12872-024-03931-x.
2
A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT).新型心脏生物标志物在急性或慢性心血管疾病中的研究进展:可溶性 ST2(sST2)、脂蛋白相关磷脂酶 A2(Lp-PLA2)、髓过氧化物酶(MPO)和降钙素原(PCT)的作用。
Dis Markers. 2021 Aug 9;2021:6258865. doi: 10.1155/2021/6258865. eCollection 2021.
3
Consumption of Enriched Yogurt with PAF Inhibitors from Olive Pomace Affects the Major Enzymes of PAF Metabolism: A Randomized, Double Blind, Three Arm Trial.橄榄油渣来源富含 PAF 抑制剂的酸奶摄入对 PAF 代谢的主要酶具有影响:一项随机、双盲、三臂试验。
Biomolecules. 2021 May 28;11(6):801. doi: 10.3390/biom11060801.
4
High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: Evidence from two large population cohort studies.高覆盖度血浆脂质组学揭示了年龄和 BMI 的新型性别特异性脂质组学特征:来自两项大型人群队列研究的证据。
PLoS Biol. 2020 Sep 28;18(9):e3000870. doi: 10.1371/journal.pbio.3000870. eCollection 2020 Sep.
5
Attenuated age-impact on systemic inflammatory markers in the presence of a metabolic burden.在存在代谢负担的情况下,年龄对全身炎症标志物的影响减弱。
PLoS One. 2015 Mar 27;10(3):e0121947. doi: 10.1371/journal.pone.0121947. eCollection 2015.
6
Obesity and lifespan health--importance of the fetal environment.肥胖与寿命健康——胎儿环境的重要性。
Nutrients. 2014 Apr 24;6(4):1725-36. doi: 10.3390/nu6041725.
7
Evaluation of lipoprotein-associated phospholipase A2 in healthy Chinese Han adult serum.载脂蛋白相关磷脂酶 A2 在健康中国汉族成年人血清中的评估。
Lipids Health Dis. 2014 Jan 7;13:6. doi: 10.1186/1476-511X-13-6.
8
Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.载脂蛋白 E4 和脂蛋白相关磷脂酶 A2 协同增加心血管风险。
Atherosclerosis. 2012 Jul;223(1):230-4. doi: 10.1016/j.atherosclerosis.2012.04.021. Epub 2012 May 8.
9
Age as a modulator of inflammatory cardiovascular risk factors.年龄作为炎症性心血管危险因素的调节剂。
Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2151-6. doi: 10.1161/ATVBAHA.111.232348. Epub 2011 Jun 23.

本文引用的文献

1
Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.脂蛋白相关磷脂酶A2活性、铁蛋白水平、代谢综合征与10年心血管及非心血管死亡率:布伦内克研究结果
Eur Heart J. 2009 Jan;30(1):107-15. doi: 10.1093/eurheartj/ehn502. Epub 2008 Nov 19.
2
Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines.将脂蛋白相关磷脂酶A2检测纳入心血管疾病风险评估指南的共识小组建议。
Am J Cardiol. 2008 Jun 16;101(12A):51F-57F. doi: 10.1016/j.amjcard.2008.04.019.
3
Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study.老年队列中脂蛋白相关磷脂酶A2的分布及其相关因素:心血管健康研究
J Am Geriatr Soc. 2008 May;56(5):792-9. doi: 10.1111/j.1532-5415.2008.01667.x. Epub 2008 Mar 21.
4
Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men.脂蛋白相关磷脂酶A2与美国和日本男性冠状动脉钙化的关联。
J Epidemiol. 2007 Nov;17(6):179-85. doi: 10.2188/jea.17.179.
5
Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study.种族和性别对脂蛋白相关磷脂酶A2水平的影响:达拉斯心脏研究的观察结果。
Atherosclerosis. 2008 Jul;199(1):110-5. doi: 10.1016/j.atherosclerosis.2007.10.010. Epub 2007 Dec 3.
6
Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.降血脂药物对脂蛋白相关磷脂酶A2的差异作用。
Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2236-43. doi: 10.1161/ATVBAHA.107.147280. Epub 2007 Jul 26.
7
Lipoprotein-associated phospholipase A2 predicts 5-year cardiac mortality independently of established risk factors and adds prognostic information in patients with low and medium high-sensitivity C-reactive protein (the Ludwigshafen risk and cardiovascular health study).脂蛋白相关磷脂酶A2独立于既定风险因素预测5年心脏死亡率,并为低和中等高敏C反应蛋白患者增加预后信息(路德维希港风险与心血管健康研究)。
Clin Chem. 2007 Aug;53(8):1440-7. doi: 10.1373/clinchem.2007.086298. Epub 2007 Jun 15.
8
Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.脂蛋白相关磷脂酶A2和溶血磷脂酰胆碱在冠状动脉循环中的局部生成:与人类早期冠状动脉粥样硬化及内皮功能障碍的关联
Circulation. 2007 May 29;115(21):2715-21. doi: 10.1161/CIRCULATIONAHA.106.671420. Epub 2007 May 14.
9
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases.对脂蛋白磷脂酶A2与心血管疾病观察性研究的个体参与者数据进行的协作荟萃分析。
Eur J Cardiovasc Prev Rehabil. 2007 Feb;14(1):3-11. doi: 10.1097/01.hjr.0000239464.18509.f1.
10
Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review.脂蛋白相关磷脂酶A2与心血管疾病的关联:一项系统评价
Mayo Clin Proc. 2007 Feb;82(2):159-65. doi: 10.4065/82.2.159.

载脂蛋白相关磷脂酶 A2 与非裔美国人和白种人冠心病的相关性。

Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians.

机构信息

Department of Medicine, University of California, Davis, California 95817, USA.

出版信息

J Clin Endocrinol Metab. 2010 May;95(5):2376-83. doi: 10.1210/jc.2009-2498. Epub 2010 Mar 1.

DOI:10.1210/jc.2009-2498
PMID:20194707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2869550/
Abstract

CONTEXT

Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is bound predominately to low-density lipoprotein and has been implicated as a risk factor for coronary artery disease (CAD).

OBJECTIVE

We investigated the association between Lp-PLA(2) and CAD in a biethnic African-American and Caucasian population.

DESIGN

Lp-PLA(2) mass, activity, and index, an integrated measure of mass and activity, and other cardiovascular risk factors were determined in 224 African-Americans and 336 Caucasians undergoing coronary angiography.

MAIN OUTCOME MEASURES

We assessed the distribution of Lp-PLA(2) levels and determined the predictive role of Lp-PLA(2) as a risk factor for CAD.

RESULTS

Levels of Lp-PLA(2) mass and activity were higher among Caucasians compared with African-Americans (293 +/- 75 vs. 232 +/- 76 ng/ml, P < 0.001 for mass and 173 +/- 41 vs. 141 +/- 39 nmol/min/ml, P < 0.001 for activity, respectively). However, Lp-PLA(2) index was similar in the two groups (0.61 +/- 0.17 vs. 0.64 +/- 0.19, P = NS). In both ethnic groups, Lp-PLA(2) activity and index was significantly higher among subjects with CAD. African-American subjects with CAD had significantly higher Lp-PLA(2) index than corresponding Caucasian subjects (0.69 +/- 0.20 vs. 0.63 +/- 0.18, P = 0.028). In multivariate regression analyses, after adjusting for other risk factors, Lp-PLA(2) index was independently (odds ratio 6.7, P = 0.047) associated with CAD in African-Americans but not Caucasians.

CONCLUSIONS

Lp-PLA(2) activity and index was associated with presence of CAD among African-Americans and Caucasians undergoing coronary angiography. The findings suggest an independent impact of vascular inflammation among African-Americans as contributory to CAD risk and underscore the importance of Lp-PLA(2) as a cardiovascular risk factor.

摘要

脂蛋白相关磷脂酶 A(2)(Lp-PLA(2))主要与低密度脂蛋白结合,并已被认为是冠心病(CAD)的一个危险因素。

目的

我们在一个非裔美国人和白种人群体中研究了 Lp-PLA(2)与 CAD 的关系。

设计

在接受冠状动脉造影的 224 名非裔美国人和 336 名白种人中,测定了 Lp-PLA(2)的质量、活性和指数(一种综合衡量质量和活性的指标)以及其他心血管危险因素。

主要观察指标

我们评估了 Lp-PLA(2)水平的分布,并确定了 Lp-PLA(2)作为 CAD 危险因素的预测作用。

结果

与非裔美国人相比,白种人的 Lp-PLA(2)质量和活性更高(分别为 293±75 vs. 232±76ng/ml,P<0.001;分别为 173±41 vs. 141±39nmol/min/ml,P<0.001)。然而,两组的 Lp-PLA(2)指数相似(分别为 0.61±0.17 vs. 0.64±0.19,P=NS)。在两个种族群体中,CAD 患者的 Lp-PLA(2)活性和指数均显著升高。CAD 非裔美国人患者的 Lp-PLA(2)指数明显高于相应的白种人患者(0.69±0.20 vs. 0.63±0.18,P=0.028)。多元回归分析显示,在校正其他危险因素后,Lp-PLA(2)指数与非裔美国人 CAD 独立相关(比值比 6.7,P=0.047),但与白种人无关。

结论

Lp-PLA(2)活性和指数与接受冠状动脉造影的非裔美国人和白种人 CAD 的存在相关。这些发现表明,血管炎症在非裔美国人中独立影响 CAD 风险,并强调了 Lp-PLA(2)作为心血管危险因素的重要性。